Publications

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

View Slides

Literature Highlights - November 2024

more…

Keywords:

systemic lupus erythematosus, randomized clinical trial, belimumab, disease activity, patient-reported outcomes, disease trajectories, Efficacy, Iberdomide, Phase 2, Safety, CLE,, SLE, Type 2 diabetes, Cardiovascular, Renal, SGLT2i

November 2021

Publication thumbnail: B-cell Depletion With Obinutuzumab for the Treatment of Proliferative Lupus Nephritis: A Randomised, Double-blind, Placebo-controlled Trial

View Slides

B-cell Depletion With Obinutuzumab for the Treatment of Proliferative Lupus Nephritis: A Randomised, Double-blind, Placebo-controlled Trial

Ann Rheum Dis. 2021. doi:10.1136/annrheumdis-2021-220920

Phase 2 study data support the use of obinutuzumab in proliferative lupus nephritis (LN) being further evaluated in a global Phase 3 study.

more…

Keywords:

Systemic Lupus Erythematosus,
Lupus Nephritis,
Rituximab;